Country Profile

Gabon

Gabon is a developing market for Indian pharmaceuticals — $3.83M in FY 2025–26. Medicines accounts for 88% of shipments, with vaccines contributing $348K.

🇬🇦 $3.83M · 1.1× growth since FY2015 · 0.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$3.83M
Exports FY2025–26 DGCIS
1.1×
Growth FY2015→2026
0.8%
CAGR FY2015→2026
88%
Medicines Share
4
Product Categories Supplied
Gabon is a developing market for Indian pharmaceuticals — $3.83M in FY 2025–26. Medicines accounts for 88% of shipments, with vaccines contributing $348K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $3.36M (87.7%) Vaccines $348K (9.1%) Medicine Ingredients $83K (2.2%) Surgical & Hospital Supplies $40K (1.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Gabon in the RBI overseas direct investment dataset (2011–2026).